XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025

Realtime	Geld	Brief	Zeit
	12,300	12,800	19:53

Realtime

Geld

Brief

Zeit

12,300

12,800

19:53

XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025

The following instruments on XETRA do have their first trading 24.06.2025
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.06.2025

Aktien

1 NL0015002J37 JBS N.V.
2 AU0000400616 Virgin Australia Holdings Ltd.
3 US1421521071 Caris Life Sciences Inc.
4 US15117F8804 Cellectar Biosciences Inc.
5 KYG2545C1042 Crescent Biopharma Inc.

6 CA3194101067 First Canadian Grahite Inc.
7 KYG3472Y1199 FIH Mobile Ltd.
8 CA75103L3092 Rakovina Therapeutics Inc.

Anleihen/ETF

1 XS3102006031 Al Mi'yar Capital S.A.
2 EU000A4EB337 Europäische Union
3 NO0013289397 Gondola Midco AS
4 US594972AN17 MicroStrategy Inc.
5 XS3094548123 OTP Jelzálogbank Részvénytársaság
6 XS3098982815 SNB Funding Ltd.
7 USN88808AE50 Trivium Packaging Finance B.V.
8 US92939UAP12 WEC Energy Group Inc.
9 XS2903447519 Hyundai Capital America
10 XS3079581479 Intesa Sanpaolo S.p.A.
11 XS3077018714 Nexi S.p.A.
12 DE000HEL4AF3 Landesbank Hessen-Thüringen Girozentrale
13 IE000CO3P697 First Trust Vest U.S. Equity Max Buffer UCITS ETF
14 IE000HFBJ0U0 First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF

Zeit	Aktuelle Nachrichten
02.12.	Canaccord Genuity initiates Caris Life Sciences stock with Hold rating
02.12.	Caris Life Sciences: Canaccord Genuity startet Coverage mit "Hold"-Rating
06.11.	Caris Life Sciences Q3 2025 slides: Revenue surges 113%, margins expand significantly
05.11.	Caris Life Sciences, Inc. GAAP EPS of $0.08 beats by $0.24, revenue of $216.8M beats by $42.58M
05.11.	Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance	Revenue growth of 113% driven by strong performance in molecular profiling services Raises 2025 revenue guidance to $720 to $730 million, representing year-over-year... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.12.

Canaccord Genuity initiates Caris Life Sciences stock with Hold rating

02.12.

Caris Life Sciences: Canaccord Genuity startet Coverage mit "Hold"-Rating

06.11.

Caris Life Sciences Q3 2025 slides: Revenue surges 113%, margins expand significantly

05.11.

Caris Life Sciences, Inc. GAAP EPS of $0.08 beats by $0.24, revenue of $216.8M beats by $42.58M

05.11.

Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Revenue growth of 113% driven by strong performance in molecular profiling services Raises 2025 revenue guidance to $720 to $730 million, representing year-over-year...
► Artikel lesen

Zeit	Aktuelle Nachrichten
13.11.	Cellectar signals 2027 global launch for iopofosine as regulatory momentum accelerates
13.11.	Cellectar Biosciences, Inc.: Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update	Expects to Submit Conditional Marketing Approval Application in Europe for Iopofosine I 131 in Refractory (post-BTKi) Waldenstrom's Macroglobulinemia in 2026 Following Advice and Guidance from Scientific... ► Artikel lesen
13.11.	Cellectar Biosciences, Inc. - 8-K, Current Report
13.11.	Cellectar Biosciences, Inc. - 10-Q, Quarterly Report
12.11.	Earnings Outlook For Cellectar Biosciences

Zeit

Aktuelle Nachrichten

13.11.

Cellectar signals 2027 global launch for iopofosine as regulatory momentum accelerates

13.11.

Cellectar Biosciences, Inc.: Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Expects to Submit Conditional Marketing Approval Application in Europe for Iopofosine I 131 in Refractory (post-BTKi) Waldenstrom's Macroglobulinemia in 2026 Following Advice and Guidance from Scientific...
► Artikel lesen

13.11.

Cellectar Biosciences, Inc. - 8-K, Current Report

13.11.

Cellectar Biosciences, Inc. - 10-Q, Quarterly Report

12.11.

Earnings Outlook For Cellectar Biosciences

Zeit	Aktuelle Nachrichten
05.12.	China's Kelun-Biotech to Earn More Than USD1.3 Billion From Cancer Drugs Licensing Deal With US' Crescent Bio
04.12.	Crescent Biopharma stock price target raised by Stifel to $32 on Kelun deal
04.12.	Crescent Bio Expands Its Cancer Drug Combo Ambitions With New Kelun-Biotech Alliance
04.12.	Partnerschaft mit Kelun-Biotech und Privatplatzierung beflügeln Aktie von Crescent Biopharma
04.12.	Morning Market Movers: Polyrizon, Picard Medical, Crescent Biopharma, Hyster-Yale See Big Swings	OTTAWA (dpa-AFX) - At 7:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen

Zeit

Aktuelle Nachrichten

05.12.

China's Kelun-Biotech to Earn More Than USD1.3 Billion From Cancer Drugs Licensing Deal With US' Crescent Bio

04.12.

Crescent Biopharma stock price target raised by Stifel to $32 on Kelun deal

04.12.

Crescent Bio Expands Its Cancer Drug Combo Ambitions With New Kelun-Biotech Alliance

04.12.

Partnerschaft mit Kelun-Biotech und Privatplatzierung beflügeln Aktie von Crescent Biopharma

04.12.

Morning Market Movers: Polyrizon, Picard Medical, Crescent Biopharma, Hyster-Yale See Big Swings

OTTAWA (dpa-AFX) - At 7:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening...
► Artikel lesen

Zeit	Aktuelle Nachrichten
04.12.	FIH (02038): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CIRCULAR DATED 5 DECEMBER 2025 FOR EXTRAORDINARY GENERAL ...
04.12.	FIH (02038): LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CIRCULAR DATED 5 DECEMBER 2025 FOR EXTRAORDINARY GENERAL MEETING ...
04.12.	FIH (02038): FORM OF PROXY
04.12.	FIH (02038): NOTICE OF EXTRAORDINARY GENERAL MEETING
04.12.	FIH (02038): NON-EXEMPT CONTINUING CONNECTED TRANSACTIONS AND NOTICE OF EXTRAORDINARY GENERAL MEETING

Zeit

Aktuelle Nachrichten

04.12.

FIH (02038): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CIRCULAR DATED 5 DECEMBER 2025 FOR EXTRAORDINARY GENERAL ...

04.12.

FIH (02038): LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CIRCULAR DATED 5 DECEMBER 2025 FOR EXTRAORDINARY GENERAL MEETING ...

04.12.

FIH (02038): FORM OF PROXY

04.12.

FIH (02038): NOTICE OF EXTRAORDINARY GENERAL MEETING

04.12.

FIH (02038): NON-EXEMPT CONTINUING CONNECTED TRANSACTIONS AND NOTICE OF EXTRAORDINARY GENERAL MEETING

Zeit	Aktuelle Nachrichten
Mi	First Canadian Graphite Inc: First Canadian Graphite increases financing to $740,000
18.11.	First Canadian Graphite Inc: First Canadian Graphite arranges financings
18.11.	First Canadian Graphite Inc. Announces Financings
24.10.	First Canadian Graphite Inc: First Canadian talks Chinese export restrictions
23.10.	First Canadian Graphite Inc.: First Canadian Graphite well positioned to Capitalize on China's Export Controls on Graphite

Zeit

Aktuelle Nachrichten

First Canadian Graphite Inc: First Canadian Graphite increases financing to $740,000

18.11.

First Canadian Graphite Inc: First Canadian Graphite arranges financings

18.11.

First Canadian Graphite Inc. Announces Financings

24.10.

First Canadian Graphite Inc: First Canadian talks Chinese export restrictions

23.10.

First Canadian Graphite Inc.: First Canadian Graphite well positioned to Capitalize on China's Export Controls on Graphite

Zeit	Aktuelle Nachrichten
18:35	JBS to close California beef plant over low US cattle supply
18:22	JBS schließt Rindfleischwerk in Kalifornien wegen angespannter Versorgungslage
Mi	EU orders recall of JBS beef after banned hormone-related alert
03.12.	Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery
26.11.	JBS merges its leather business with Viva to create a new corporate entity

Zeit

Aktuelle Nachrichten

18:35

JBS to close California beef plant over low US cattle supply

18:22

JBS schließt Rindfleischwerk in Kalifornien wegen angespannter Versorgungslage

EU orders recall of JBS beef after banned hormone-related alert

03.12.

Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery

26.11.

JBS merges its leather business with Viva to create a new corporate entity

Zeit	Aktuelle Nachrichten
Mi	Rakovina Therapeutics Inc (2): Rakovina to host webinar with Variational AI on Dec. 17
01.12.	Rakovina Therapeutics Inc (2): Rakovina's Q3 R&D expenses at $1.1-million
01.12.	Rakovina Therapeutics reports Q3 results
01.12.	Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Three-Month Q3 ended September 30, 2025 Financial Results and Provides Corporate Update	All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V:... ► Artikel lesen
29.11.	Rakovina Therapeutics Inc (2): Rakovina debentureholders consent to maturity extension

Zeit

Aktuelle Nachrichten

Rakovina Therapeutics Inc (2): Rakovina to host webinar with Variational AI on Dec. 17

01.12.

Rakovina Therapeutics Inc (2): Rakovina's Q3 R&D expenses at $1.1-million

01.12.

Rakovina Therapeutics reports Q3 results

01.12.

Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Three-Month Q3 ended September 30, 2025 Financial Results and Provides Corporate Update

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V:...
► Artikel lesen

29.11.

Rakovina Therapeutics Inc (2): Rakovina debentureholders consent to maturity extension

Zeit	Aktuelle Nachrichten
Do	Virgin Australia versus Qantas shares: One I'd buy and one I'd sell
Mi	Virgin Australia kehrt auf Strecke Sydney - Darwin zurück
Di	CHINA SOUTH AIR Forges Code-Sharing Deal with Virgin Australia
Mo	China Southern signs codeshare deal with Virgin Australia
28.11.	Virgin Australia arbeitet für Flugsuche mit Open AI zusammen

Zeit

Aktuelle Nachrichten

Virgin Australia versus Qantas shares: One I'd buy and one I'd sell

Virgin Australia kehrt auf Strecke Sydney - Darwin zurück

CHINA SOUTH AIR Forges Code-Sharing Deal with Virgin Australia

China Southern signs codeshare deal with Virgin Australia

28.11.

Virgin Australia arbeitet für Flugsuche mit Open AI zusammen

Unternehmen / Aktien	Kurs	%
CARIS LIFE SCIENCES INC	22,800	0,00 %
CELLECTAR BIOSCIENCES INC	3,680	-3,29 %
CRESCENT BIOPHARMA INC	12,300	+6,03 %
FIH MOBILE LTD	2,140	-1,83 %
FIRST CANADIAN GRAPHITE INC	0,101	-9,01 %
JBS NV	12,000	-0,83 %
RAKOVINA THERAPEUTICS INC	0,067	+0,60 %
VIRGIN AUSTRALIA HOLDINGS LIMITED	1,800	0,00 %

Unternehmen / Aktien

Kurs

CARIS LIFE SCIENCES INC

22,800

0,00 %

CELLECTAR BIOSCIENCES INC

3,680

-3,29 %

CRESCENT BIOPHARMA INC

12,300

+6,03 %

FIH MOBILE LTD